Abstract: A physiological information processing method executed by a computer. The physiological information processing method includes obtaining a plurality of electroencephalogram signals indicating an electroencephalogram of a subject, using a plurality of electrodes attached to a head of the subject, each of the plurality of electroencephalogram signals being associated with a respective one of the plurality of electrodes, obtaining, from each of the plurality of electroencephalogram signals, a plurality of artifact component signals indicating different types of artifacts, calculating effective values of the plurality of artifact component signals of each of the electroencephalogram signals, determining whether the effective value of each of the artifact component signals of the electroencephalogram signal satisfies a predetermined condition, and visually presenting information related to the artifact associated with the artifact component signal of which the effective value satisfies the predetermined condition.

Abstract: A battery charger is provided on which power conversion components for converting commercial power to direct current (DC) power are mounted. The power conversion components include a power breaker for switching input alternate current (AC) power on/off, a power conversion circuit for converting the input AC power to a predetermined AC power, a voltage conversion circuit for converting the predetermined AC power to a predetermined voltage, and a rectifier circuit for converting the AC power that has been converted to the predetermined voltage to DC power. The power conversion components are mounted on a core frame, and an outer housing is mounted to the core frame in a manner so as to cover the core frame. The power breaker, the power conversion circuit, the rectifier circuit, and the voltage conversion circuit are mounted in this order to the core frame.

Abstract: A battery charger on which power conversion components for converting commercial power to direct current power are mounted, includes a core frame formed into a C-letter shape in horizontal cross section. The components at least producing heat among the power conversion components are mounted on one side confined by a C-letter cross section of its both sides. An outer housing is attached to the core frame so as to cover the core frame, and a fan supplies cooling air to a region confined by the C-letter shaped cross section of the core frame.

Abstract: A battery charger is provided on which power conversion components for converting commercial power to direct current (DC) power are mounted. The power conversion components include a power breaker for switching input alternate current (AC) power on/off, a power conversion circuit for converting the input AC power to a predetermined AC power, a voltage conversion circuit for converting the predetermined AC power to a predetermined voltage, and a rectifier circuit for converting the AC power that has been converted to the predetermined voltage to DC power. The power conversion components are mounted on a core frame, and an outer housing is mounted to the core frame in a manner so as to cover the core frame. The power breaker, the power conversion circuit, the rectifier circuit, and the voltage conversion circuit are mounted in this order to the core frame.

Abstract: A battery charger on which power conversion components for converting commercial power to direct current power are mounted, includes a core frame formed into a C-letter shape in horizontal cross section. The components at least producing heat among the power conversion components are mounted on one side confined by a C-letter cross section of its both sides. An outer housing is attached to the core frame so as to cover the core frame, and a fan supplies cooling air to a region confined by the C-letter shaped cross section of the core frame.

Abstract: A polyester represented by the following general formula (I) and a copolymer which comprises two structural units represented by the following general formulae (I') and (II). ##STR1## and a coating material for use in large intestine-selective drug release pharmaceutical preparations, which contains the above polyester and/or copolymer. The polyester and copolymer of the present invention contain a saccharide residue which is hydrolyzed and/or assimilated specifically in the large intestine, drugs contained in solid oral pharmaceutical administration pharmaceutical preparations coated with the coating material of the present invention are not decomposed or absorbed by digestive organs other than the large intestine, but instead are released selectively and therefore in a high concentration in the large intestine.

Abstract: A polyester represented by the following general formula (I) and a copolymer which comprises two structural units represented by the following general formulae (I') and (II). ##STR1## and a coating material for use in large intestine-selective drug release pharmaceutical preparations, which contains the above polyester and/or copolymer. The polyester and copolymer of the present invention contain a saccharide residue which is hydrolyzed and/or assimilated specifically in the large intestine, drugs contained in solid oral pharmaceutical administration pharmaceutical preparations coated with the coating material of the present invention are not decomposed or absorbed by digestive organs other than the large intestine, but instead are released selectively and therefore in a high concentration in the large intestine.

Abstract: A polyester represented by the following general formula (I) and a copolymer which comprises two structural units represented by the following general formulae (I') and (II). ##STR1## and a coating material for use in large intestine-selective drug release pharmaceutical preparations, which contains the above polyester and/or copolymer. The polyester and copolymer of the present invention contain a saccharide residue which is hydrolyzed and/or assimilated specifically in the large intestine, drugs contained in solid oral pharmaceutical administration pharmaceutical preparations coated with the coating material of the present invention are not decomposed or absorbed by digestive organs other than the large intestine, but instead are released selectively and therefore in a high concentration in the large intestine.

Abstract: The present invention is directed to a sticky composition for medical use comprising a tackifier resin and an oxyalkylene polymer having a silicon-containing group which can be crosslinked by forming a siloxane bond, wherein silicon atom thereof is bound with a hydroxyl group or hydrolytic group, and to a transdermal drug delivery preparation incorporating said sticky composition as a drug carrier. The sticky composition of the present invention possesses excellent adhesive properties, very low skin irritancy and good compatibility with the site of plastering and thus perform as a very safe and effective medical adhesive. The transdermal drug delivery preparation of the present invention offers excellent drug release from the sticky composition.

Abstract: The present invention relates to a method for producing a microgranulated particle having particle size of not more than 0.2 mm, wherein a fine powder with the average particle size of not more than 10 .mu.m, which is being agitated, tumbled or fluidized, is granulated, with a solution containing a binder alone or a binder and a surfactant being sprayed onto the surface thereof. The present invention allows to produce pharmaceutical preparations for poorly soluble and poorly absorbable drugs and preparations requiring a high content of the active ingredient. Also, it can provide an easy-to-handle powdery microgranulated particle in the field of food and fertilizers.

Abstract: The present invention is directed to a stable pharmaceutical composition wherein the absorbability of a lipophilic drug which is insoluble or practically insoluble in water or another drug such as a bioactive peptide in oral administration has been improved to such extent that a high level of blood concentration can be retained, and to a method for producing such a stable pharmaceutical composition. The pharmaceutical composition of the present invention offers improvements in the absorbability, for example, a high level of blood concentration can be retained for a long time in oral administration because it is highly resistant to lipase. Also, the pharmaceutical composition is highly safe because the emulsifier used is derived from mammalian milk.

Abstract: A lead storage battery having electro-collecting boards of lead or lead alloys, and active material layers closely contacted with the electro-collecting boards. The active material layers are integrally formed with the electro-collecting boards by providing a mixture, in the form of slurry, of an active material powder and a liquid to the electro-collecting boards, and then drying the mixture.